Micronbrane Medical Introduces PaRTI-Cular™ in Collaboration with Basepair and AWS to Advance Infectious Disease Testing

Clinical Study Finds the Company’s Devin™ Fractionation Membrane and Metagenomics Assay is More Accurate and Faster than Blood Cultures and Assays without a Host Depletion Filter.

TAOYUAN CITY, TAIWAN, September 29, 2022 — Micronbrane Medical, a biotechnology start-up developing metagenomic-based technologies, today announced it raised $4.5 million in A round funding